feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics",https://benzinga.com/general/biotech/21/05/21192868/the-daily-biotech-pulse-iovance-to-delay-regulatory-filing-for-cancer-therapy-departures-at-passa,https://j.mp/3hxxFR8
Benzinga,Iovance's Lifileucel US Application Submission Pushed To 2022,https://benzinga.com/general/biotech/21/05/21191572/iovances-lifileucel-us-application-submission-pushed-to-2022,https://j.mp/3yk27Ee
